Sue Desmond-Hellmann: A smarter, more precise way to think about public health
Sue Desmond-Hellmann: Wie wir das Gesundheitswesen schlauer und präziser anpacken können
Sue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person. Full bio
Double-click the English transcript below to play the video.
ein paar Leute vorstellen.
Theresa Marie.
und Theresa Marie.
and Kevin Michael's on his right.
und Kevin Michael ist rechts von ihm.
was picking names.
number seven came along,
on Jennifer Bridget.
Jennifer Bridget entschieden.
ceremonial moment.
feierlichen Moment zu helfen.
for their new babies
für ihre Babys auszusuchen,
of this special ceremonial time?
feierliche Zeit genießen?
bearable without a name.
vielleicht etwas leichter zu ertragen.
dreaming of the future of that child --
und träumen von der Zukunft des Kindes --
of a future for their child
für ihr Kind zu träumen,
kostbare Wochen hinausgeht.
an updated pie chart.
ein aktualisiertes Tortendiagram.
under five worldwide."
unter fünf Jahren weltweit"
of that pie chart, about 40 percent --
des Diagramms, ungefähr 40 Prozent --
is less than one month old.
dass das Kind jünger als einen Monat ist.
"We have no idea."
"Wir haben keine Ahnung".
what you can't define.
die man nicht beschreiben kann.
the dreams of those parents
dieser Eltern war also der erste Schritt,
about a new approach,
einen neuen Ansatz sprechen,
know why babies are dying,
die Todesursache von Babys herauszufinden,
im Gesundheitswesen".
from a very special place.
ein ganz besonderes Verhältnis.
an oncologist.
Krebserkarnkungen, also Onkologin.
to help people feel better.
helfen wollte, sich besser zu fühlen.
made them feel worse.
durch meine Behandlung schlechter.
being driven to my clinic
die in meine Praxis gebracht wurden.
into my exam room by their mothers.
gestützt werden mussten.
in the war on cancer,
im Kampf gegen den Krebs,
couldn't differentiate
konnten wir nicht unterscheiden
that we wanted to hit hard
die wir schwer treffen wollten,
that we wanted to preserve.
die wir erhalten wollten.
all very familiar with --
die Sie alle kennen --
so infection was a constant threat --
sodass ständig Infektionen drohen --
to the biotechnology industry.
for breast cancer patients
für Brustkrebspatienten,
of telling the healthy cells
von ungesunden oder Krebszellen
HER2-positive breast cancer,
zielgenau angreifen.
form of breast cancer.
Form von Brustkrebs.
hit hard the cancer cells,
wir gleichzeitig die Krebszellen angreifen
gentle on the normal cells.
sehr viele Methoden nutzen --
gene sequencing and more --
Gensequenzierung und weitere --
zur richtigen Zeit einsetzen.
revolutionized cancer therapy.
hat die Krebstherapie revolutioniert.
better way to tackle diseases
bessere Art, Krankheiten zu behandeln,
expensive medicines like Herceptin
teure Medikamente wie Herceptin
targeting for individuals
bei einzelnen Menschen anzuwenden,
you're thinking, "She's crazy.
denken Sie: "Die spinnt doch.
to make a big difference.
einen großen Unterschied.
as a cancer doctor.
ausgebildete Onkologin.
who trained in San Francisco in the '80s,
in San Francisco ausgebildet wurden,
a terrible global challenge.
riesige globale Herausforderung.
are living with HIV.
Frauen den HIV-Virus in sich.
become pregnant,
bei einer Schwangerschaft
until the age of two.
als zwei Jahre wird.
can virtually guarantee
Therapien praktisch garantieren können,
the virus to the baby.
auf ihr Baby überträgt.
kind of like that blast of chemo,
wie damals bei der Chemotherapie,
every pregnant woman in the world.
zu testen und zu behandeln.
where HIV rates are the highest.
die Regionen mit den meisten HIV-Fällen.
in sub-Saharan Africa
in Subsahara-Afrika,
where rates are highest.
Schwangere testen und behandeln können.
bei einem öffentlichen Gesundheitsproblem
to a public health problem
in certain areas in the developing world
in bestimmten Entwicklungsländern
can change things on a big scale.
Dinge im großen Stil verändern kann.
elements of precision public health:
Präzisionsmedizin im Gesundheitswesen:
to the 2.6 million babies
zu den 2,6 Millionen Babys,
the causes of infant mortality
für Kindersterblichkeit
with the highest infant mortality
höchsten Kindersterberate nur
who has just lost her child,
die gerade ihr Kind verloren hat,
Did they have a fever?"
Hatte es Fieber?"
after the baby has died.
in the shoes of that mom.
Sie wären die Mutter.
excruciating conversation.
entsetzliches Gespräch.
vielleicht führt es zu nichts,
there was a fever or vomiting,
dass das Kind Fieber hatte
that knowledge,
a precision public health approach?
im Gesundheitswesen anwenden?
because of a bacterial infection
bakteriellen Infektion sterben,
mom has a seven times higher chance
ein sieben Mal höheres Risiko,
we can prevent that death
können wir diesen Tod verhindern --
and safe as penicillin.
Sicherem wie Penizillin.
the right interventions
können wir entsprechend eingreifen,
in the right places
und auf den Ort,
and with these interventions
im Gesundheitswesen
our 15-year goal.
unser 15-Jahres-Ziel erreichen.
into a million babies' lives saved
von einer Million Babys
to public health --
im Gesundheitswesen --
was alles möglich wäre!
tackle malnutrition?
wirksamer angehen?
cervical cancer in women?
bei Frauen verhindern?
in two different worlds,
verschiedenen Welten.
by public health professionals.
die im Gesundheitswesen arbeiten.
Gesundheitswesen hat das Potenzial,
wir leben alle in zwei Welten:
about precision public health
im Gesundheitswesen ist für mich,
diesen Welten zu schlagen.
talent and tools --
in ways I never imagined
that kind of talent and tools
Talente und Methoden nutzen,
the confidence
the moment that child is born,
wenn es geboren wird,
will be measured in decades,
Kinderleben in Jahrzehnten zu messen,
ABOUT THE SPEAKER
Sue Desmond-Hellmann - CEO, Gates FoundationSue Desmond-Hellmann leads the Bill & Melinda Gates Foundation’s mission to establish equity for every person.
Why you should listen
As CEO of the Bill & Melinda Gates Foundation, Sue Desmond-Hellmann leads the organization's vision for a world where every person has the opportunity to live a healthy, productive life. Drawing on her diverse experience as scientist, physician and business executive, she oversees a variety of missions focused on eradicating disease, poverty and inequity. She leads 1,400 people, across four continents, working in more than 100 countries to help more children and young people survive and thrive, combat infectious diseases that hit the poorest hardest, and empower people -- particularly women and girls -- to transform their lives.
Trained as an oncologist, Dr. Desmond-Hellmann spent 14 years at biotech firm Genentech, developing a number of breakthrough medicines, including two of the first gene-targeted therapies for cancer, Avastin and Herceptin. In November 2009, Forbes magazine named her one of the world's seven most "powerful innovators," calling her "a hero to legions of cancer patients." Her time at Genentech put her at the forefront of the precision medicine revolution, and in her current role she champions a similar approach to global development: precision public health -- getting the right interventions, to the right populations, in the right places, to save lives.
Immediately prior to joining the foundation in 2014, Dr. Desmond-Hellmann was the first female chancellor of the University of California at San Francisco (UCSF), overseeing all aspects of the university and medical center's strategy and operations. It was her second stint at UCSF, having completed her clinical training there in the 1980s. She moved to Uganda in 1989 to work on HIV/AIDS and cancer, which she credits as a turning point in her career. "It was so profound to recognize ... that all the learning I had done to become a doctor didn't matter at all if I didn’t make a contribution," she said.
Dr. Desmond-Hellmann is the recipient of numerous honors and awards. She was listed among Fortune magazine's "50 most powerful women in business" for seven years. In 2010, she was inducted into the American Academy of Arts and Sciences and elected to the Institute of Medicine. She serves on the boards of directors at Facebook Inc. and the Procter & Gamble Company.
Sue Desmond-Hellmann | Speaker | TED.com